3 terminated. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vision Response to Dopamine Replacement Levodopa/carbidopa - Albinism, Oculocutaneous Albinism | Phase 2 | Terminated | University of Wisconsin, Madison | 20 | 2012-10-17 | 2019-06-11 |
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis | Phase 1 / Phase 2 | Terminated | National Human Genome Research Institute (NHGRI) | 3 | 2007-04-01 | 2013-08-02 |
| T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Stem Cell Transplant, Myeloablative conditioning regimen - Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders | Phase 2 / Phase 3 | Terminated | Masonic Cancer Center, University of Minnesota | 22 | 2000-09-01 | 2018-01-23 |
Albinism, Oculocutaneous (2) · Chediak-Higashi Syndrome (1) · Hematologic Diseases (1) · Hermanski-Pudlak Syndrome (1) · Histiocytosis, Langerhans-Cell (1) · Immune System Diseases (1) · Lung Diseases (1) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoproliferative Disorders (1) · Metabolic Diseases (1) · Platelet Storage Pool Deficiency (1) · Pulmonary Fibrosis (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Eye Diseases (3) · Eye Diseases, Hereditary (3) · Genetic Diseases, Inborn (3) · Amino Acid Metabolism, Inborn Errors (2) · Hemic and Lymphatic Diseases (2) · Hypopigmentation (2) · Lung Diseases, Interstitial (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Pigmentation Disorders (2) · Respiratory Tract Diseases (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2)
Acetylcysteine (1) · Busulfan (1) · Cyclophosphamide (1) · Erythromycin (1) · Losartan (1) · Pravastatin (1) · Stem Cell Transplantation (1) · carbidopa, levodopa drug combination (1) · zileuton (1)
Masonic Cancer Center, University of Minnesota (1) · National Human Genome Research Institute (NHGRI) (1) · University of Wisconsin, Madison (1)
United States (3)
Angela Smith, MD (1) · Michael C Struck, MD (1) · Thomas Markello, M.D. (1)